Review emphasizes recent advancements in spirocyclopropyl oxindoles for diverse therapeutic applications, highlighting challenges and opportunities.
In the recent past, spirooxindoles have been evolved as captivating structural architectures for the medicinal chemists, owing to their diverse biological activities. In particular, the development of spirocyclopropyl oxindole heterocycles has gained enormous attention as anti-HIV, anti-cancer and anti-viral agents. The incorporation of a cyclopropyl moiety within the oxindole framework has emerged as a powerful tool in modulating physicochemical and biological properties. This review delineates the medicinal chemistry landscape with a comprehensive overview of recent advances, developments in the design and synthesis of spirocyclopropyl oxindole derivatives and summarizes their biological activities across diverse therapeutic areas. Key insights into the mechanism of action were discoursed. In detail, structure-activity relationships (SARs) have been emphasized on how cyclopropyl incorporation modulates the physicochemical and pharmacological profile relative to conventional oxindole analogues in few cases. An emphasis was placed highlighting the interaction of spirocyclopropyl oxindole derivatives with diverse molecular targets. In addition, current challenges, knowledge gaps, and emerging opportunities for further optimization are discussed, positioning these strained ring systems as a promising and evolving chemical space in the modern medicinal chemistry. Future efforts prioritizing this under explored scaffold would unlock new avenues in the development of novel therapeutics.
No takes yet. Share an insight, caveat, or question.
Dastari et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: